Details

Autor(en) / Beteiligte

• Soeiro-de-Souza, Marcio Gerhardt
• Teixeira, Antonio L
• Mateo, Elvis C
• Zanetti, Marcus V
• Rodrigues, Flavia G
• de Paula, Vanessa J
• Bezerra, Julia F
• Moreno, Ricardo A
• Gattaz, Wagner F
• Machado-Vieira, Rodrigo

Titel

Leukocyte telomerase activity and antidepressant efficacy in bipolar disorder

Ist Teil von

• European neuropsychopharmacology, 2014-07, Vol.24 (7), p.1139-1143

Ort / Verlag

Netherlands: Elsevier B.V

Erscheinungsjahr

2014

Quelle

Access via ScienceDirect (Elsevier)

Beschreibungen/Notizen

• Abstract Telomeres are DNA-protein complexes that cap linear DNA strands, protecting DNA from damage. Recently, shorten telomeres length has been reported in bipolar disorder (BD) and depression. The enzyme telomerase regulates telomeres׳ length, which has been associated with cellular viability; however it is not clear how telomerase may be involved in the pathophysiology and therapeutics of BD. In the present study, leukocyte telomerase activity was assessed in 28 medication-free BD depressed individuals (DSM-IV-TR criteria) at baseline and after 6 weeks of lithium therapy ( n =21) also matching with 23 healthy controls. There was no difference between telomerase activity in subjects with BD depression (before or after lithium) and controls. Improvement of depressive symptoms was negatively associated with telomerase activity after 6 weeks of lithium therapy. This is the first study describing telomerase activity in BD research. Overall, telomerase activity seems not directly involved in the pathophysiology of short-term BD. Lithium׳s antidepressant effects may involve regulation at telomerase activity. Further studies with larger samples and long-term illness are also warranted.